Does Rallies show Form 4 insider transactions for MDT?

Yes. Rallies tracks MDT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is MDT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MDT. It does not provide personalized investment advice.

MDT (Medtronic) Stock Analysis - Insider Trades

Medtronic (MDT) is a publicly traded Healthcare sector company. As of May 20, 2026, MDT trades at $77.78 with a market cap of $99.27B and a P/E ratio of 21.02. MDT moved -0.65% today. Year to date, MDT is -18.19%; over the trailing twelve months it is -9.65%. Its 52-week range spans $74.40 to $106.33. Analyst consensus is buy with an average price target of $105.58. Rallies surfaces MDT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading MDT stock inside the company?

Recent MDT insider activity includes KIIL HARRY SKIP sold 1.65K, KIIL HARRY SKIP sold 30.57K, KIIL HARRY SKIP sold 19.25K, KIIL HARRY SKIP sold 668, and KIIL HARRY SKIP sold 385. Rallies tracks insider transaction dates, shares, prices, and estimated values.

MDT Key Metrics

Key financial metrics for MDT
Metric	Value
Price	$77.78
Market Cap	$99.27B
P/E Ratio	21.02
EPS	$3.72
Dividend Yield	0.71%
52-Week High	$106.33
52-Week Low	$74.40
Volume	7.66M
Avg Volume	0
Revenue (TTM)	$34.76B
Net Income	$4.79B
Gross Margin	65.51%

Recent MDT Insider Trades

KIIL HARRY SKIP sold 1.65K (~$161.27K) on Feb 19, 2026.
KIIL HARRY SKIP sold 30.57K (~$2.99M) on Feb 19, 2026.
KIIL HARRY SKIP sold 19.25K (~$1.88M) on Feb 19, 2026.
KIIL HARRY SKIP sold 668 (~$65.35K) on Feb 19, 2026.
KIIL HARRY SKIP sold 385 (~$37.66K) on Feb 19, 2026.

Latest MDT News

Medtronic falls 3% as MiniMed insulin pump recalls weigh; shares hit 52-week low — Apr 29, 2026
Medtronic Acquires CathWorks for $585M, Expands AI-Driven FFRangio System — Apr 29, 2026
Medtronic’s Stealth AXiS Secures CE Mark for Spine, Cranial Robotics — Apr 28, 2026
Medtronic says cybersecurity breach contained, no disruption to products or finances — Apr 27, 2026
Medtronic’s Target Slashed to $95 as Perfusion Market Eyes $2.4B by 2034 — Apr 23, 2026

MDT Analyst Consensus

20 analysts cover MDT: 0 strong buy, 12 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $105.58.

Common questions about MDT

Who is trading MDT stock inside the company?: Recent MDT insider activity includes KIIL HARRY SKIP sold 1.65K, KIIL HARRY SKIP sold 30.57K, KIIL HARRY SKIP sold 19.25K, KIIL HARRY SKIP sold 668, and KIIL HARRY SKIP sold 385. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MDT?: Yes. Rallies tracks MDT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MDT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MDT. It does not provide personalized investment advice.